PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 11 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Used as a component in the Unani formulation Qurse Tabasheer for diabetes treatment [PMID:27034607]. (Note: A related animal study on Qurs Tabasheer has been retracted [PMID:36397076]).
Traditionally used in the Unani formulation Qurs Tabasheer Sarthani [PMID:33964191].
Evidence summary
PubMed sources
- 1.PMID: 31459924 (2019) — Plant-Derived Tandem Drug/Mesoporous Silicon Microcarrier Structures for Anti-Inflammatory Therapy. · ACS omega
- 2.PMID: 37082912 (2023) — Green synthesis of mesoporous and biodegradable iron silicide nanoparticles for photothermal cancer therapy. · Journal of materials chemistry. B
- 3.PMID: 27034607 (2016) — Standardization of Unani Antidiabetic Tablet - Qurse Tabasheer. · Pharmacognosy research
- 4.PMID: 29111753 (2017) — Biogenic Nanostructured Porous Silicon as a Carrier for Stabilization and Delivery of Natural Therapeutic Species. · Molecular pharmaceutics
- 5.PMID: 27684478 (2016) — Single Plant Derived Nanotechnology for Synergistic Antibacterial Therapies.